# Naive review of request 17: model roles

## Restatement of the task

The request asks the model to review two pretreatment candidate measurements using modeling evidence from one outer-training fold. It must first identify themes across candidates and then assign each candidate zero or more of the roles `confounder` and `effect_modifier`. The reasoning must distinguish treatment prediction, outcome prognosis, confounding, and treatment-effect heterogeneity; account for the stated analysis populations and evaluability denominators; reconcile evidence across methods and inner folds; preserve investigator-locked roles; and avoid treating methods, p-values, support fractions, theme membership, or correlated proxies as dispositive.

The supplied input contains:

- Analysis-population rules for association and modifier evidence, including inclusive propensity bounds of 0.1 to 0.9.
- Two unlocked candidates: continuous serum creatinine and binary emphysema.
- Three evidence records per candidate, each evaluated in three inner folds.
- Two supplied themes, one containing each candidate.
- A mapping from model family to score interpretation.
- A requested response structure consisting of an overall `summary` and a `decisions` array with one decision per candidate.

The expected output is JSON. Each candidate must appear exactly once in `decisions`. Each decision must provide its `feature_id`, selected `roles`, evidence for and against, cited evidence IDs, fold consistency, cross-method reconciliation, rationale, and a stability label of `consistent`, `mixed`, or `insufficient`. Modifier decisions are to cite effect evidence; confounder decisions are to cite treatment and outcome evidence. Only supplied evidence IDs may be cited.

## Can this be executed without consequential hidden assumptions?

Not fully. A useful evidence synthesis can be written from the supplied facts, and the input is sufficient to describe the observed patterns. However, final role assignment and parts of the exact JSON representation require policies that are not specified. Choosing those policies silently could change whether creatinine is labeled a confounder, whether either candidate is labeled an effect modifier, and whether the response passes a strict schema validator.

The largest substantive gap is the inferential standard for `confounder`. Creatinine has treatment-prediction support in 2/3 folds and outcome-prediction support in 3/3 folds, but those predictive associations alone cannot distinguish a pretreatment common cause from an instrument, a purely prognostic variable, or a proxy. The system explicitly asks the model to discuss that distinction and forbids inventing hidden truth, but it does not say whether a plausible common-cause interpretation is enough to assign the role or whether the role must remain unassigned when causal direction is unresolved.

The effect-modifier threshold is also underspecified. Creatinine has causal-forest effect support in 1/3 folds. Emphysema has nominal univariable interaction support in 2/3 folds, but probability-scale R-learner and causal-forest support each occurs in only 1/3 folds, all in inner fold 1. The prompt correctly says no individual method or support frequency is a hard gate, but supplies no affirmative adjudication rule for deciding when mixed, scale-dependent evidence crosses from “possible signal” to the `effect_modifier` role. Different reasonable standards yield different roles.

The `stability` labels have an allowed vocabulary but no operational definitions. For example, emphysema could be called `mixed` because methods disagree, or `insufficient` because only one fold has cross-method support and the evidence comes from one outer-training fold. Creatinine's main-effect evidence could be `consistent` overall, while its modifier evidence is weak; it is unclear whether `stability` summarizes the assigned role, all evidence for the candidate, or each role jointly.

There is also a response-shape ambiguity. The instructions say to identify themes first, but `required_response` has no theme-analysis field. Theme discussion could be placed in `summary`, embedded in candidate rationales, or emitted as an extra top-level field. Those choices matter if the output is validated strictly. Similarly, `roles` is described as `["confounder and/or effect_modifier, or empty"]`, which strongly suggests an array of exact strings such as `["confounder", "effect_modifier"]`, but this is an example-like description rather than a formal schema.

## Concrete clarification questions that could change the output

1. What evidentiary standard should control a `confounder` assignment when a pretreatment candidate predicts both treatment and outcome but the supplied evidence cannot establish that it is a common cause rather than an instrument, prognostic-only factor, or proxy? Should the model assign `confounder` when common-cause status is clinically plausible, or leave the role empty while explicitly describing the unresolved alternatives?

2. What standard should determine an `effect_modifier` assignment under conflicting method and fold evidence? In particular, should emphysema's 2/3 unadjusted log-odds interaction support plus 1/3 support in each probability-scale method qualify, or should the concentration of all cross-method support in inner fold 1 prevent assignment? Should creatinine's 1/3 causal-forest support ever qualify on its own?

3. Does `stability` refer only to the roles ultimately assigned, to the candidate's complete evidence profile, or to the weakest/strongest role-specific evidence? How should `mixed` be distinguished from `insufficient`?

4. Where must the required initial theme identification appear? Must it be folded into the top-level `summary`, or is an additional top-level `themes` field allowed?

5. Is the JSON schema strict? Specifically, must `roles` be an array containing only the exact tokens `confounder` and `effect_modifier`, must evidence fields be arrays of strings, and are additional keys prohibited?

6. For `evidence_against`, should absence of support in explicitly evaluated folds be stated as a fact, while unevaluated or missing evidence is excluded? This matters because the system says missing/nonconverged fits are not negative votes, but the expected representation of evaluated unsupported folds is not specified.

## Contradictions and tensions

There is no direct numerical or identifier contradiction in the supplied input.

There is a structural tension between “first identify themes across candidates” and the absence of a theme-specific field in `required_response`. This is resolvable only by choosing where theme analysis belongs or allowing an extra field.

There is an intentional evidentiary tension, rather than a contradiction, in the emphysema evidence: univariable interaction support appears in folds 1 and 2, whereas both probability-scale methods support only fold 1. The prompt itself warns that these methods target different scales and have different biases, so the records should not be treated as direct replications.

There is also an intentional tension for creatinine: strong treatment/outcome predictive support is compatible with confounding but does not identify a common-cause relationship. The prompt asks the model to distinguish that relationship without supplying causal-direction evidence. That is an underdetermination, not an inconsistency.

The renal theme's `disagreements` text says there is little effect evidence while its sole theme-level evidence ID is a treatment record. This does not contradict the candidate data, which contains a weak 1/3 causal-forest effect result, but the theme-level citation does not itself substantiate the statement about effect evidence. Because definitions and themes cannot establish roles, candidate-level evidence must carry the decision.

## Identifier, index, format, and arithmetic bookkeeping suitable for Python

Python could verify the following deterministically without making substantive role choices:

- Parse both the outer message JSON and the JSON string contained in the user message.
- Confirm candidate-level `feature_id` equals `definition.feature_id` for both candidates.
- Confirm candidate feature IDs are unique and each appears exactly once in the output decisions.
- Confirm every evidence ID is unique, begins with the corresponding candidate feature ID in the expected position, and is cited only in that candidate's decision.
- Confirm modifier role citations refer only to records whose `role` is `effect`, and confounder citations include both `treatment` and `outcome` records.
- Confirm every theme `member_feature_ids` entry resolves to a supplied candidate and every theme `evidence_ids` entry resolves to a supplied evidence record.
- Confirm inner-fold indices are 1, 2, and 3 with no duplicates or gaps within each record.
- Confirm `evaluated` equals the sum of fold-level `evaluated`, `supported` equals the sum of fold-level `supported`, `not_evaluable` equals `exposures - evaluated`, and `support_fraction` equals `supported / evaluated` when evaluated is nonzero. All six supplied records satisfy these relationships.
- Confirm fold-level `supported` does not exceed fold-level `evaluated`, and aggregate `supported` does not exceed aggregate `evaluated` or `exposures`.
- Confirm the propensity bounds satisfy minimum <= maximum and apply inclusively as stated; here they are 0.1 and 0.9.
- Confirm every evidence family has a corresponding entry in `score_meaning`. The supplied families (`penalized_main`, `causal_forest`, `univariable`, and `univariable_rlearner`) are all covered.
- Confirm output `stability` values belong to the allowed set and output role values, once formally clarified, belong to the allowed role vocabulary.
- Confirm the output is valid JSON with no prose outside it, if that is the intended serialization requirement.

Python cannot determine whether predictive associations warrant a confounder label, how much heterogeneous-treatment-effect evidence warrants an effect-modifier label, or how to reconcile different estimands. Those are substantive adjudication policies and should not be disguised as validation logic.
